Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Biol. Res ; 48: 1-10, 2015. ilus, graf
Article Dans Anglais | LILACS | ID: biblio-950800

Résumé

BACKGROUND: The antiepileptic drugs carbamazepine and gabapentin are effective in treating neuropathic pain and trigeminal neuralgia. In the present study, to analyze the effects of carbamazepine and gabapentin on neuronal excitation in the spinal trigeminal subnucleus caudalis (Sp5c) in the medulla oblongata, we recorded temporal changes in nociceptive afferent activity in the Sp5c of trigeminal nerve-attached brainstem slices of neonatal rats using a voltage-sensitive dye imaging technique. RESULTS: Electrical stimulation of the trigeminal nerve rootlet evoked changes in the fluorescence intensity of dye in the Sp5c. The optical signals were composed of two phases, a fast component with a sharp peak followed by a long-lasting component with a period of more than 500 ms. This evoked excitation was not influenced by administration of carbamazepine (10, 100 and 1,000 µM) or gabapentin (1 and 10 µM), but was increased by administration of 100 µM gabapentin. This evoked excitation was increased further in low Mg²+ (0.8 mM) conditions, and this effect of low Mg²+ concentration was antagonized by 30 µM DL-2-amino-5-phosphonopentanoic acid (AP5), a N-methyl-D-as-partate (NMDA) receptor blocker. The increased excitation in low Mg²+ conditions was also antagonized by carbamazepine (1,000 µM) and gabapentin (100 µM). CONCLUSION: Carbamazepine and gabapentin did not decrease electrically evoked excitation in the Sp5c in control conditions. Further excitation in low Mg²+ conditions was antagonized by the NMDA receptor blocker AP5. Carbamazepine and gabapentin had similar effects to AP5 on evoked excitation in the Sp5c in low Mg²+ conditions. Thus, we concluded that carbamazepine and gabapentin may act by blocking NMDA receptors in the Sp5c, which contributes to its anti-hypersensitivity in neuropathic pain.


Sujets)
Animaux , Rats , Névralgie essentielle du trijumeau/traitement médicamenteux , Noyau spinal du nerf trijumeau/effets des médicaments et des substances chimiques , Carbamazépine/pharmacologie , Acides cyclohexanecarboxyliques/pharmacologie , Imagerie par colorant sensible au potentiel , Acide gamma-amino-butyrique/pharmacologie , Amines/pharmacologie , Anticonvulsivants/pharmacologie , Névralgie essentielle du trijumeau/physiopathologie , Noyau spinal du nerf trijumeau/physiopathologie , Potentiels d'action/effets des médicaments et des substances chimiques , Potentiels d'action/physiologie , Voies afférentes/effets des médicaments et des substances chimiques , Voies afférentes/physiologie , Rat Wistar , Gabapentine , Animaux nouveau-nés
SÉLECTION CITATIONS
Détails de la recherche